AAAAAA
Results: 1-25/28
Authors:
HOFSTRA LS
KRISTENSEN GB
WILLEMSE PHB
VINDEVOGHEL A
MEDEN H
LAHOUSEN M
OBERLING F
SORBE B
CRUMP M
SKLENAR I
SLUITER WJ
KIESE B
TROPE CG
DEVRIES EGE
Citation: Ls. Hofstra et al., RANDOMIZED TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-3 VERSUS PLACEBO INPREVENTION OF BONE-MARROW DEPRESSION DURING FIRST-LINE CHEMOTHERAPY FOR OVARIAN-CARCINOMA, Journal of clinical oncology, 16(10), 1998, pp. 3335-3344
Authors:
NORDAL RR
KRISTENSEN GB
STENWIG AE
TROPE CG
NESLAND JM
Citation: Rr. Nordal et al., IMMUNOHISTOCHEMICAL ANALYSIS OF P53 PROTEIN IN UTERINE SARCOMAS, Gynecologic oncology (Print), 70(1), 1998, pp. 45-48
Authors:
BJORGE T
ENGELAND A
HANSEN S
TROPE CG
Citation: T. Bjorge et al., PROGNOSIS OF PATIENTS WITH OVARIAN-CANCER AND BORDERLINE TUMORS DIAGNOSED IN NORWAY BETWEEN 1954 AND 1993, International journal of cancer, 75(5), 1998, pp. 663-670
Authors:
BJORGE T
ENGELAND A
SUNDFOR K
TROPE CG
Citation: T. Bjorge et al., PROGNOSIS OF 2,800 PATIENTS WITH EPITHELIAL OVARIAN-CANCER DIAGNOSED DURING 1975-94 AND TREATED AT THE NORWEGIAN RADIUM HOSPITAL, Acta obstetricia et gynecologica Scandinavica, 77(7), 1998, pp. 777-781
Authors:
DORUM A
MOLLER P
KAMSTEEG EJ
SCHEFFER H
BURTON M
HEIMDAL KR
MAEHLE LO
HOVIG E
TROPE CG
VANDERHOUT AH
VANDERMEULEN MA
BUYS CHCM
MEERMAN GJT
Citation: A. Dorum et al., A BRCA1 FOUNDER MUTATION, IDENTIFIED WITH HAPLOTYPE ANALYSIS, ALLOWING GENOTYPE PHENOTYPE DETERMINATION AND PREDICTIVE TESTING/, European journal of cancer, 33(14), 1997, pp. 2390-2392
Authors:
NORDAL RR
KRISTENSEN GB
STENWIG AE
NESLAND JM
PETTERSEN EO
TROPE CG
Citation: Rr. Nordal et al., AN EVALUATION OF PROGNOSTIC FACTORS IN UTERINE CARCINOSARCOMA, Gynecologic oncology, 67(3), 1997, pp. 316-321
Authors:
BJORGE T
ENGELAND A
HANSEN S
TROPE CG
Citation: T. Bjorge et al., TRENDS IN THE INCIDENCE OF OVARIAN-CANCER AND BORDERLINE TUMORS IN NORWAY, 1954-1993, International journal of cancer, 71(5), 1997, pp. 780-786
Authors:
KRISTENSEN GB
KARLSEN F
JENKINS A
KAERN J
ABELER VM
TROPE CG
Citation: Gb. Kristensen et al., HUMAN PAPILLOMA-VIRUS HAS NO PROGNOSTIC-SIGNIFICANCE IN CERVICAL-CARCINOMA, European journal of cancer, 32A(8), 1996, pp. 1349-1353
Authors:
DORUM A
KRISTENSEN GB
ABELER VM
TROPE CG
MOLLER P
Citation: A. Dorum et al., EARLY DETECTION OF FAMILIAL OVARIAN-CANCER, European journal of cancer, 32A(10), 1996, pp. 1645-1651
Authors:
SUNDFOR K
TROPE CG
KJORSTAD KE
Citation: K. Sundfor et al., RADICAL RADIOTHERAPY VERSUS BRACHYTHERAPY PLUS SURGERY IN CARCINOMA OF THE CERVIX 2A AND 2B - LONG-TERM RESULTS FROM A RANDOMIZED STUDY 1968-1980, Acta oncologica, 35, 1996, pp. 99-107
Authors:
NORDAL RR
KRISTENSEN GB
KAERN J
STENWIG AE
PETTERSEN EO
TROPE CG
Citation: Rr. Nordal et al., THE PROGNOSTIC-SIGNIFICANCE OF SURGERY, TUMOR SIZE, MALIGNANCY GRADE,MENOPAUSAL STATUS, AND DNA-PLOIDY IN ENDOMETRIAL STROMAL SARCOMA, Gynecologic oncology, 62(2), 1996, pp. 254-259
Authors:
KRISTENSEN GB
HOLM R
ABELER VM
TROPE CG
Citation: Gb. Kristensen et al., EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF NM23 NDP KINASE PROTEIN EXPRESSION IN CERVICAL-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY/, Gynecologic oncology, 61(3), 1996, pp. 378-383
Authors:
ABELER VM
VERGOTE IB
KJORSTAD KE
TROPE CG
Citation: Vm. Abeler et al., CLEAR-CELL CARCINOMA OF THE ENDOMETRIUM - PROGNOSIS AND METASTATIC PATTERN, Cancer, 78(8), 1996, pp. 1740-1747
Authors:
KRISTENSEN GB
HOLM R
ABELER VM
TROPE CG
Citation: Gb. Kristensen et al., EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF CATHEPSIN-D, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND C-ERBB-2 IN EARLY CERVICAL SQUAMOUS-CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY, Cancer, 78(3), 1996, pp. 433-440
Authors:
SUNDFOR K
TROPE CG
HOGBERG T
ONSRUD M
KOERN J
SIMONSEN E
BERTELSEN K
WESTBERG R
Citation: K. Sundfor et al., RADIOTHERAPY AND NEOADJUVANT CHEMOTHERAPY FOR CERVICAL-CARCINOMA - A RANDOMIZED MULTICENTER STUDY OF SEQUENTIAL CISPLATIN AND 5-FLUOROURACIL AND RADIOTHERAPY IN ADVANCED CERVICAL-CARCINOMA STAGE 3B AND 4A, Cancer, 77(11), 1996, pp. 2371-2378
Authors:
KRISTENSEN GB
HOLM R
ABELER VM
TROPE CG
Citation: Gb. Kristensen et al., THE PROGNOSTIC-SIGNIFICANCE OF NM23, CATHEPSIN-D, EGFR AND C-ERBB-2 IN CERVICAL-CANCER, European journal of cancer, 31A, 1995, pp. 1184-1184
Authors:
NORDAL RR
KRISTENSEN GB
KAERN J
STENWIG AE
PETTERSEN EO
TROPE CG
Citation: Rr. Nordal et al., THE PROGNOSTIC-SIGNIFICANCE OF STAGE, TUMOR SIZE, CELLULAR ATYPIA ANDDNA-PLOIDY IN UTERINE LEIOMYOSARCOMA, Acta oncologica, 34(6), 1995, pp. 797-802
Authors:
KRISTENSEN GB
KAERN J
ABELER VM
HAGMAR B
TROPE CG
PETTERSEN EO
Citation: Gb. Kristensen et al., NO PROGNOSTIC IMPACT OF FLOW-CYTOMETRIC MEASURED DNA-PLOIDY AND S-PHASE FRACTION IN CANCER OF THE UTERINE CERVIX - A PROSPECTIVE-STUDY OF 465 PATIENTS, Gynecologic oncology, 57(1), 1995, pp. 79-85
Authors:
MAKAR AP
BAEKELANDT M
TROPE CG
KRISTENSEN GB
Citation: Ap. Makar et al., THE PROGNOSTIC-SIGNIFICANCE OF RESIDUAL DISEASE, FIGO SUBSTAGE, TUMORHISTOLOGY, AND GRADE IN PATIENTS WITH FIGO STAGE-III OVARIAN-CANCER, Gynecologic oncology, 56(2), 1995, pp. 175-180
Authors:
MAKAR AP
HOLM R
KRISTENSEN GB
NESLAND JM
TROPE CG
Citation: Ap. Makar et al., THE EXPRESSION OF C-ERBB-2 (HER-2 NEU) ONCOGENE IN INVASIVE OVARIAN MALIGNANCIES/, International journal of gynecological cancer, 4(3), 1994, pp. 194-199
Authors:
KAERN J
TROPE CG
KRISTENSEN GB
PETTERSEN EO
Citation: J. Kaern et al., FLOW CYTOMETRIC DNA-PLOIDY AND S-PHASE HETEROGENEITY IN ADVANCED OVARIAN-CARCINOMA, Cancer, 73(7), 1994, pp. 1870-1877
Authors:
KAERN J
TROPE CG
KRISTENSEN GB
TVEIT KM
PETTERSEN EO
Citation: J. Kaern et al., EVALUATION OF DEOXYRIBONUCLEIC-ACID PLOIDY AND S-PHASE FRACTION AS PROGNOSTIC PARAMETERS IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA - A PROSPECTIVE-STUDY, American journal of obstetrics and gynecology, 170(2), 1994, pp. 479-487
Authors:
KAERN J
TROPE CG
KRISTENSEN GB
ABELER VM
PETTERSEN EO
Citation: J. Kaern et al., DNA-PLOIDY - THE MOST IMPORTANT PROGNOSTIC FACTOR IN PATIENTS WITH BORDERLINE TUMORS OF THE OVARY, International journal of gynecological cancer, 3(6), 1993, pp. 349-358
Authors:
MAKAR AP
KAERN J
KRISTENSEN GB
VERGOTE I
BORMER OP
TROPE CG
Citation: Ap. Makar et al., EVALUATION OF SERUM CA-125 LEVEL AS A TUMOR-MARKER IN BORDERLINE TUMORS OF THE OVARY, International journal of gynecological cancer, 3(5), 1993, pp. 299-303
Authors:
MAKAR AP
KRISTENSEN GB
BORMER OP
TROPE CG
Citation: Ap. Makar et al., IS SERUM CA-125 AT THE TIME OF RELAPSE A PROGNOSTIC INDICATOR FOR FURTHER SURVIVAL PROGNOSIS IN PATIENTS WITH OVARIAN-CANCER, Gynecologic oncology, 49(1), 1993, pp. 3-7